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2096Background: We present a series of patients who underwent in situ total aortic arch replacement for infected
distal aortic arch aneurysms.
Methods: Between 2002 and 2013, 9 patients with infected distal aortic arch aneurysms underwent total aortic
arch replacement using antegrade selective cerebral perfusion. There were 4 male and 5 female patients with a
mean age of 72.7  9.0 years. All patients had penetrating atherosclerotic ulcer in the distal aortic arch, which
formed saccular aneurysms. Four patients had preoperative hoarseness. Maximum preoperative white blood cell
count was 10,211  4375/mL, and mean serum C-reactive protein concentration was 12.7  7.2 mg/dL.
Causative microorganisms were identified by blood culture or aortic wall culture and were as follows: Candida
albicans, Pseudomonas aeruginosa, Edwardsiella tarda, Streptococcus dysgalactiae, Listeria monocytogenes,
Staphylococcus aureus (2 cases), and unknown (2 cases). Radical debridement with in situ total aortic arch
replacement was performed in all patients, followed by the omental flap grafting in 7 patients. All surgery
was performed on an urgent or emergency basis.
Results: Average cardiopulmonary bypass time and lower body circulatory arrest time were 199.7  50.7
minutes and 66.6 13.8 minutes, respectively. There was no in-hospital mortality, but 1 patient died of asphyxia
5 months after hospital discharge. Freedom from recurrence of infection was 100%.
Conclusions: Surgical treatment with the combination of radical debridement with in situ total
aortic arch replacement using antegrade selective cerebral perfusion and omental flap grafting was a
reliable procedure for the treatment of infected distal aortic arch aneurysms. (J Thorac Cardiovasc Surg
2014;148:2096-100)Although treatments of aortic arch aneurysm have
been improving during the past decade,1,2 infected
aneurysms are one of the most intractable aortic
pathologies, which complicate the surgical procedure
and might cause recurrence of infection with high
mortality. Controversy continues over the role of in situ
reconstruction,3 extra-anatomic bypass,4 or thoracic
endovascular aortic repair (TEVAR),5-7 and there are
few studies that have focused on the reconstruction of
infected aortic arch aneurysms. We describe a series of
cases treated with radical debridement of infected aortic
walls followed by in situ reconstruction combined with
omental flap grafting and advanced antibiotic therapy
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The Journal of Thoracic and Cardiovascular SurMATERIALS AND METHODS
A retrospective review of the cardiovascular surgical database at
Kobe University Graduate School of Medicine was performed for the
period from January 2002 to August 2013. The medical records were
reviewed for preoperative risk factors, operative records, intraoperative
events, and postoperative course. This retrospective study was approved
by the institutional review board at Kobe University (#1490). The need
for individual consent was waived. During the period noted, consecutive
423 patients underwent total aortic arch replacement (TAR) using ante-
grade selective cerebral perfusion through a median sternotomy, and 9
(2.1%) of them with a mean age of 72.7  9.0 years had infected aortic
arch aneurysms. The diagnosis of infected aneurysms was made by a
combination of clinical presentation, blood test, computed tomography
(CT) imaging, positive bacterial growth on blood/aortic tissue culture,
intraoperative Gram staining, and inflammatory change in the
pathologic specimens. Transverse contrast-enhanced CT generally
demonstrated an irregular multiloculated arterial wall, periaortic edema,
a periaortic soft-tissue mass, or periaortic gas.8 Patients with aortic arch
aneurysms–associated bronchial fistula or esophageal fistula were
excluded in this study, because the former was difficult to diagnose
as infectious aneurysms, and the latter was treated by a completely
different surgical strategy. Patient profiles are shown in Table 1.
Preoperative CT scan demonstrated that all patients had penetrating
atherosclerotic ulcer (PAU) in the distal aortic arch, which formed
saccular aneurysms (Figure 1). PAU was defined as a focal
contrasted-filled outpouching of the aorta through intimal calcified
plaque using CT scan. Four of 9 patients had preoperative hoarseness.
All patients had ongoing fever before surgery. The duration from the
infection onset was 36.6  56.9 days (range, 0 day to 6 months).
Preoperative blood culture was positive in 3 of 9 patients. Five of 9gery c November 2014
Abbreviations and Acronyms
CRP ¼ C-reactive protein
CT ¼ computed tomography
PAU ¼ penetrating atherosclerotic ulcer
TAR ¼ total aortic arch replacement
TEVAR ¼ thoracic endovascular aortic repair
Okada et al Acquired Cardiovascular Disease
A
C
Dpatients had undergone antibiotic therapy before surgery, and the
duration ranged from 9 days to 6 months.
The standardized surgical procedure of TAR used at Kobe University
Graduate School of Medicine has been reported.2 Surgical indication and
urgency were determined by the type of aneurysm (saccular) with clinical
symptom (chest pain, back pain, and sudden development of hoarseness)
and active infection (ongoing fever, increased white blood cell count,
and C-reactive protein [CRP] level) despite the use of antibiotics. All
patients underwent TAR on an urgent/emergency basis (1.8 2.1 days after
admission). After cardiopulmonary bypass was established, tympanic
temperature had decreased to 20C to 23C, and rectal temperature was
less than 30C, the aortic arch was opened and antegrade selective cerebral
perfusion was started. The distal aortic arch or the descending aorta was
transected at the distal clear level of the infected aneurysms, followed by
debridement of the infected tissue and aneurysmal wall, and copious saline
irrigation. Intraoperative Gram staining was performed in 6 of 9 patients,
and resected aneurysm walls were subjected to both tissue culture and
pathologic examinations in all patients. Intraoperative Gram staining was
positive in 3 of 6 patients, and culture of resected aortic wall was
positive for bacterial growth in 7 of 9 patients. A gelatin-impregnated
quadrifurcated Dacron graft (Gelweave, Vascutek Ltd, Terumo Corp,
Scotland, UK, or J Graft Shield Neo, Japan Lifeline, Tokyo, Japan) was
used. Rifampicin soaking of the gelatin-sealed Dacron graft was performed
in 8 of 9 patients. After completion of the distal anastomosis of the
prosthetic graft, lower body circulation was restarted thorough a branch
graft, and the tympanic/rectal temperature was rewarmed early to 33C.
The proximal anastomosis of the graft was completed followed by coronary
reperfusion. Finally, the aortic arch vessels were reconstructed. In 7 of 9
patients, the omental flap was prepared and installed around the prosthetic
graft to separate the surrounding tissue after debridement.
Subsequently, the causative microorganisms were identified by blood
culture or aortic wall culture and were as follows: Candida albicans,
Pseudomonas aeruginosa, Edwardsiella tarda, Streptococcus dysgalac-
tiae, Listeria monocytogenes, and Staphylococcus aureus (2 cases).
Negative culture was obtained in 2 patients (numbers 5 and 6). Intravenous
antibiotic therapy based on sensitivity data was continued for 6 weeks
postoperatively, and prolonged antibiotic therapy was continued according
to the clinical course (fever), blood test parameters (WBC and CRP levels),
and CT imaging.
Statistical Analysis
Continuous variables were expressed as mean  standard deviation.
Survival and freedom from recurrence of infection were assessed by the
Kaplan–Meier method using SPSS software (SPSS Inc, Chicago, Ill).RESULTS
Average operation time was 507.3  163.9 minutes,
cardiopulmonary bypass time was 199.7  50.7 minutes,
myocardial ischemic time was 92.0  16.7 minutes, lower
body circulatory arrest time was 66.7  13.8 minutes,
and antegrade selective cerebral perfusion time was
136.4  29.6 minutes. Average minimum tympanic andThe Journal of Thoracic and Carrectal temperatures were 21.6C  1.3C and 26.3C 
1.4C, respectively. The 30-day mortality and in-hospital
mortality were 0%. Average duration of postoperative
hospital stay was 47.0  33.8 days. No newly developed
neurologic deficits were observed. One patient had
refractory methicillin-resistant Staphylococcus aureus
pneumonia, followed by tracheostomy. Two patients
(numbers 5 and 7) had iatrogenic hoarseness caused by
radical debridement of infected aneurysmal walls, and 3
patients had atrial fibrillation. None of the patients
experienced persistent bacteremia.
Follow-up was completed in all cases, and average
duration of follow-up was 25.0  23.6 months (range,
0.8-69.7 months). One late death (patient number 2)
occurred 5 months after the operation and was caused by
asphyxia. Freedom from recurrence of infection was
100% during the follow-up (Figure 2).
Representative findings of pathology of the resected
aortic walls demonstrated infiltration of neutrophils,
formation of abscess (Figure 3, A and B), and the presence
of gram-positive cocci by Gram staining (Figure 3, C).
DISCUSSION
Infected aortic aneurysm is a rare but formidable medical
condition associated with mortality ranging from 4.3% to
36%.3,9,10 Weis-Muller and associates11 demonstrated
that the mortality was highly dependent on the status of
rupture at the time of surgery, but the ratio in patients
with contained rupture was still as high as 30%. There
are few sporadic reports that have specifically focused on
the infected aneurysms located in the aortic arch, with a
reported mortality ranging from 0% to 10%.3,10 There is
no known reliable strategy for the treatment of infected
distal aortic arch aneurysms. The current study provided
information regarding the clinical presentation of this
sample of patients and their profiles, as well as
satisfactory outcomes, including survival and freedom
from recurrent infection.
Presenting symptoms are often nonspecific. All patients
had consistent fever, and the final diagnosis was obtained
by CT scan. Four of 9 patients (numbers 1, 2, 4, and 6)
(44.4%) had progressive hoarseness, and 7 patients had a
history of chest and back pain. Tokmaji and colleagues12
demonstrated that preoperative progressive hoarseness
was a rare clinical presentation,12 but in the patients in
this study the incidence was as high as 44.4%.
With regard to aortic pathology, although a recent report
by Nathan and associates13 demonstrated PAU location in
the aortic arch in 7% and in the descending thoracic aorta
in 62%, all patients in this study had PAUwith severe calci-
fication in the distal aortic arch. Stellmes and associates7
also showed that PAU was a cause of aortic pathology in
the native aortic infection. However, whether PAU is likely
to be associated with infection remains controversial.diovascular Surgery c Volume 148, Number 5 2097
TABLE 1. Patient profiles
No
Age,
y Sex DM
Maximum
WBC,
mL
Maximum
CRP,
mg/dL
Clinical symptoms
except fever
and comorbidity Microorganism
Preoperative
antibiotics
Duration
on
antibiotics
Culture Omental
flap
graftingBlood
Gram
staining
Aortic
tissue
1 61 M No 8000 5.73 Hoarseness, chest
pain, iliopsoas
muscle abscess,
history of left
CIA aneurysm
(Salmonella)
Candida
albicans
Yes 6 mo after
iliac
operation
Negative NA Positive Yes
2 79 M No 5700 0.89 Hoarseness Pseudomonas
aeruginosa
Yes 17 d Negative NA Positive No
3 79 M Yes 12,200 17.6 Back pain
Laryngeal cancer
tracheostomy
Edwardsiella
tarda
Yes 12 d Negative Positive
GPC
Positive Yes
4 59 F Yes 14,700 20.6 General fatigue
Hoarseness
Streptococcus
dysgalactiae
No NA Positive Negative Positive Yes
5 64 F No 7400 17.8 Back pain
Infected AAA
Unknown Yes 9 d Negative Negative Negative Yes
6 79 F No 9400 15.1 Hoarseness,
back pain
CAD
Unknown Yes 18 d Negative Negative Negative Yes
7 75 F Yes 4300 10.1 Chest pain
Liver cirrhosis
Child–Pugh
type A, AF
Listeria
monocytogenes
No NA Positive Positive
GPR
Positive Yes
8 84 F No 12,600 20.4 Back pain
Osteoporosis,
on steroid
Staphylococcus
aureus
No NA Positive Positive
GPC
Positive Yes
9 74 M Yes 17,600 6.1 Back pain
Left side
hemothorax
S aureus No NA Negative NA Positive No
AAA, Abdominal aortic aneurysm; AF, atrial fibrillation; CAD, coronary artery disease; CIA, common iliac artery; CRP, C-reactive protein; DM, diabetes mellitus;
GPC, gram-positive coccus; GPR, gram-positive rod; NA, not applicable; WBC, white blood cell.
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a negative culture for both blood and resected pathology
tissue sections, and in these cases the diagnosis was
determined by clinical presentation, blood test, and CT
imaging. Microscopic findings in these patients showed
the formation of lymphoid follicle (number 5) and
neutrophil filtration (number 6) in the resected aortic wall,
which also suggested the presence of infection. Negative
blood cultures have been reported in up to 25% of cases
and may be due to antibiotic pretreatment or anaerobic
organisms, which could also account for negative culture
results of the resected pathology tissue sections.9,14 In the
current study, we also speculate that the long duration of
preoperative antibiotics therapy ranging from 9 days to 6
months in 5 of 9 patients caused the low incidence of
bacteremia (3/9, 33.3%).
In the early reports, extra-anatomic bypass was selected
just to avoid prosthetic graft infection.9 We believe that
infected aneurysms in the aortic arch are not anatomically
amenable to extra-anatomic bypass, and in situ replacement2098 The Journal of Thoracic and Cardiovascular Surof TAR is the preferred method of selection as long as
aggressive debridement of any infected tissue and the
aneurysmal wall is performed. TAR for the treatment of
infected aortic arch aneurysms is still a surgical challenge
for organ protection because deep hypothermic circulatory
arrest time is prolonged because of the requirement of the
aggressive debridement with severe inflammation and
more distal anastomosis. Indeed, average deep hypothermic
arrest time was longer in the current study compared with
our previous report (66.6  13.8 minutes vs 42.4  27.8
minutes).2 Hsu and Lin3 have reported excellent outcomes
for the treatment of infected aortic arch in 10 patients.
However, they applied retrograde cerebral perfusion under
deep hypothermia for 80 minutes, and consequently
3 patients (30%) had hypoxic encephalopathy. Ante-
grade selective cerebral perfusion is a preferable
brain-protection method under prolonged circulatory arrest
time.
Previous reports showed a recurrence of infection even
after eradication by resection of the infected aortic wall andgery c November 2014
FIGURE 1. Preoperative findings of CT scan. All patients had PAU with calcification in the distal aortic arch, which formed saccular aneurysms.
The aneurysm of patient number 8 was growing in a caudal direction onto the pulmonary trunk. The aneurysm of patient number 9 ruptured into the
left pleural cavity with the formation of a hemothorax.
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advocated that covering the prosthetic graft with an omental
flap around it decreased the risk of recurrence of infection
during follow-up.10,15,16 Although we prefer to apply the
omental flap in every case unless there is a history of
laparotomy (patient number 9), 1 patient (number 2) did
not undergo omental flap grafting because we did not
suspect the presence of infection because there were no
positive data for infection in the blood test results (elevated
WBC counts and serum CRP concentration) before surgery.Survival
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FIGURE 2. Survival and freedom from recurrence of infection. The su
The Journal of Thoracic and CarIn this case, infection of the aortic aneurysm was identified
postoperatively by aortic wall culture.
TEVAR is an emerging minimally invasive treatment. In
a recent report, Stellmes and associates7 demonstrated the
efficacy of TEVAR in 6 patients for suspected aortic
infection in an emergency treatment situation. In their
study, TEVAR was performed as a bridge treatment in 3
of the 6 patients, and eventually open conversion was
required. We believe that TEVAR is useful as an alternative
treatment for patients with circulatory collapse or fistulaFreedom from recurrence of infection
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FIGURE 3. Representative findings of pathology of resected aortic walls. A, Hematoxylin–eosin staining (patient number 8). Asterisk shows the media of
the aortic wall. Arrowheads demonstrate the abscess formation, and arrows demonstrate hemorrhage in the outgrowth adventitia. B, Hematoxylin–eosin
staining in large scale (patient number 8) demonstrates infiltration of neutrophils and lymphocyte growth. C, Gram staining (patient number 9) demonstrates
the intramural presence of gram-positive cocci.
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esophagus,17,18 to improve a patient’s condition while
awaiting open repair.Study Limitations
This was a retrospective study from a single center. The
mean follow-up period was short (25.0  23.6 months;
range, 0.8-69.7 months).CONCLUSIONS
This study provided information regarding the clinical
presentation, the patients’ profile, and the aortic pathology
of infected aortic arch aneurysms. Surgical treatment with
a combination of radical debridement followed by in situ
TAR with omental flap grafting was a reliable procedure.References
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